Key result
Advanced carotid atherosclerosis is linked to ~45% lower miR-126-5p levels versus moderate disease.
Why the study?
Carotid atherosclerosis is a major risk factor for ischemic stroke, but the miRNA and hemostasis profiles across moderate and advanced disease stages, and their potential correlations, required description.
Does advanced carotid atherosclerosis correlate with specific microRNA expression and hemostasis profiles compared to moderate carotid atherosclerosis?
Case-Control (n=61)
No
Does advanced carotid atherosclerosis correlate with specific microRNA expression and hemostasis profiles compared to moderate carotid atherosclerosis?
Down-regulation of miR-126-5p is a promising, highly specific and sensitive biomarker of advanced carotid atherosclerosis, reflecting an interplay with hemostatic activation.
Answers are grounded in this paper and cite their sources.
miR-126-5p down-regulation may mark advanced carotid atherosclerosis; hypothesis-generating for biomarker utility, requiring prospective validation.
Carotid atherosclerosis (CA) is an important risk factor for ischemic stroke. We described the miRNA and hemostasis profile of patients with moderate and advanced stages of carotid atherosclerosis and elucidated potential correlations with hemostatic activation. A prospective case-control study included 61 patients with evidence of carotid atherosclerosis (via ultrasound). The study population was divided into groups depending on the degree of carotid artery stenosis: 60% or more (advanced) and <60% (moderate). All patients underwent the following blood tests: general blood test, hemostatic parameters and microRNA. Extraction of microRNA was performed using Leukocyte RNA Purification Kit (NORGEN Biotec Corp., Thorold, ON, Canada); miRNA quantification was performed via RT-PCR. Statistical analysis was performed in R programming language (v. 4.1.0) using RSudio. MicroRNA expression profile was different depending on CA degree. MiR-33a-5p/3p levels were higher in patients with ≥60% carotid stenosis (42.70 and 42.45 versus 38.50 and 38.50, respectively, p < 0.05). Almost complete separation can be visualized with the levels of miR-126-5p: 9.50 in the moderate CA group versus 5.25 in the advanced CA (p < 0.001). MiR-29-5p was higher in the moderate CA group: 28.60 [25.50;33.05] than in advanced CA group: 25.75 [24.38;29.50] (p = 0.086); miR-29-3p was also higher in the moderate CA group: 10.36 [8.60;14.99] than in advanced CA group: 8.46 [7.47;10.3] (p = 0.001). By-group pairwise correlation analyses revealed at least three clusters with significant positive correlations in the moderate CA group: miR-29-3p with factors V and XII (r = 0.53 and r = 0.37, respectively, p < 0.05); miR-21-5p with ADAMTS13, erythrocyte sedimentation rate and D-dimer (r = 0.42, r = 0.36 and r = 0.44, respectively, p < 0.05); stenosis degree with miR-33a-5p/3p and factor VIII levels (r = 0.43 (both) and r = 0.62, respectively, p < 0.05). Hemostasis parameters did not reveal significant changes in CA patients: the only statistically significant differences concerned factor VIII, plasminogen and (marginally significant) ADAMTS-13 and protein C. Down-regulation of miR-126-5p expression has been identified as a promising biomarker of advanced carotid atherosclerosis with high specificity and sensitivity. Correlation cluster analysis showed potential interplay between miRNAs and hemostatic activation in the setting of carotid atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Raskurazhev et al. (2022) conducted a case-control in Carotid Atherosclerosis (n=61). Advanced carotid atherosclerosis (≥60% stenosis) vs. Moderate carotid atherosclerosis (<60% stenosis) was evaluated on miR-126-5p expression level (p=<0.001). Advanced carotid atherosclerosis was associated with significant down-regulation of miR-126-5p expression compared to moderate atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: